116 related articles for article (PubMed ID: 2688658)
1. Immune complex formation between IgM rheumatoid factor and IgG generated by hyaluronic acid.
Faaber P; van den Bersselaar LA; van de Putte LB; van den Berg WB
Arthritis Rheum; 1989 Dec; 32(12):1521-7. PubMed ID: 2688658
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin phagocytosis by granulocytes from sera and synovial fluids in various rheumatoid and nonrheumatoid diseases.
Cats A; Lafeber GJ; Klein F
Ann Rheum Dis; 1975 Apr; 34(2):146-55. PubMed ID: 806270
[TBL] [Abstract][Full Text] [Related]
4. Human IgG rheumatoid factors and RF-like immune complexes induce IgG1 rheumatoid factor production in mice.
Abedi-Valugerdi M; Ridderstad A; al-Balaghi S; Möller E
Scand J Immunol; 1995 Jun; 41(6):575-82. PubMed ID: 7770728
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
6. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
O'Sullivan MM; Amos N; Williams BD
Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
[TBL] [Abstract][Full Text] [Related]
7. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
Doekes G; Schouten J; Cats A; Daha MR
Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
[TBL] [Abstract][Full Text] [Related]
8. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
9. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid factors in the pathogenesis of rheumatoid arthritis.
Mannik M
J Rheumatol Suppl; 1992 Jan; 32():46-9. PubMed ID: 1613732
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor.
Davidson A; Lopez J; Sun D; Prus D
J Immunol; 1992 Jun; 148(12):3873-8. PubMed ID: 1376343
[TBL] [Abstract][Full Text] [Related]
12. Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis.
Robbins DL; Wistar R
J Rheumatol; 1985 Jun; 12(3):437-43. PubMed ID: 3900391
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic RFs which correlate with disease parameters and with the gal(0) glycoform of IgG.
Newkirk MM; Fournier MJ; Shiroky J
J Clin Immunol; 1995 Sep; 15(5):250-7. PubMed ID: 8537469
[TBL] [Abstract][Full Text] [Related]
14. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
[TBL] [Abstract][Full Text] [Related]
15. Synovial IgG rheumatoid factors show evidence of an antigen-driven immune response and a shift in the V gene repertoire compared to IgM rheumatoid factors.
Randen I; Pascual V; Victor K; Thompson KM; Førre O; Capra JD; Natvig JB
Eur J Immunol; 1993 Jun; 23(6):1220-5. PubMed ID: 8500520
[TBL] [Abstract][Full Text] [Related]
16. Allotypic dependency of the specificity and avidity of human monoclonal IgM rheumatoid factors derived from rheumatoid synovial cells.
Robbins DL; Kenny TP; Snyder LL; Ermel RW; Larrick JW
Arthritis Rheum; 1993 Mar; 36(3):389-93. PubMed ID: 8452583
[TBL] [Abstract][Full Text] [Related]
17. IgM-RF prevents complement-mediated inhibition of immune precipitation.
Mitchell WS; Naama JK; Veitch J; Whaley K
Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
[TBL] [Abstract][Full Text] [Related]
19. 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in patients with rheumatoid arthritis.
Moore TL; Dorner RW; Zuckner J
J Lab Clin Med; 1986 May; 107(5):465-70. PubMed ID: 3701193
[TBL] [Abstract][Full Text] [Related]
20. Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor.
Shingu M; Ezaki I; Nobunaga M
Rheumatol Int; 1988; 8(3):95-100. PubMed ID: 3175453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
